<img alt="" src="https://secure.agile-company-247.com/261975.png" style="display:none;">

Deal Of The Year under £500m-1

Hosted by 

Baker McKenzie 300x



This award recognises the teams and organisations who have executed a truly transformational and high value creating deal for both the company and the wider industry. The deal could be a licensing agreement, co-development or a creative alliance or partnership that unlocks significant value.

Qualifying criteria

  • Deal size must be less than €500m
  • The lead company must be a European Life Science company
  • Open to private or public companies WITH peers, pharma, commercial leaders or big tech
  • Deal can be either a licensing deal, single asset acquisition or collaborative agreement involving a particular drug, project or group of drugs/projects
  • A license, partnership or alliance between companies NOT M&A
  • Deal to have completed in the period between 1 September 2021 and 1 September 2022

Judges will be paying particular attention to:

  • Uniqueness or novelty of deal strategy / terms and structure
  • Level of value creation / size of deal (upfront, milestone and total value)
  • Strength of partner / partnership and deal teams
  • Potential game / industry changing implications within next 12-months
  • Post-deal performance
Before entering the nomination site please ensure you have:

1. Selected the most appropriate category(s) you'll be entering and check for validity of entry
2. Identified your lead applicant / internal champion who will respond to any correspondence from the ELA team
3. Pre-prepared your submission in accordance with the category criteria, spending time crafting your detailed submission.